Skip to main content
MIT Corporate Relations
MIT Corporate Relations
Search
×
Read
Watch
Attend
About
Connect
MIT Startup Exchange
Search
Sign-In
Register
Search
×
MIT ILP Home
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
User Menu and Search
Search
Sign-In
Register
MIT ILP Home
Toggle menu
Search
Sign-in
Register
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
1.23.24-Japan-Prather
Conference Video
|
Duration: 41:17
January 23, 2024
Preview
1.23.24-Japan-Prather
Please
login
to view this video.
Video details
Biological systems have the potential to produce a wide array of compounds with uses that include fuels, materials, bulk chemicals, and pharmaceuticals. Our group is focused on applying principles from metabolic engineering and biocatalysis toward the design and construction of novel biosynthetic pathways for specified target compounds. This “retro-biosynthetic design” approach is aided by advancements in the development of new tools under the umbrella of synthetic biology that facilitate the re-engineering of biological systems. As new pathways are designed and constructed, typical challenges such as low product yields and titers can hamper the development of commercially relevant processes. The sheer volume of chemicals that ultimately need to be produced also requires the use of a broader range of feedstocks than those traditionally employed in bioprocesses. In this talk, Professor Prather will review her group’s sustained efforts to both produce novel compounds through biological synthesis and develop strategies to address the inherent limitations.
Locked Interactive transcript
Please
login
to view this video.
Video details
Biological systems have the potential to produce a wide array of compounds with uses that include fuels, materials, bulk chemicals, and pharmaceuticals. Our group is focused on applying principles from metabolic engineering and biocatalysis toward the design and construction of novel biosynthetic pathways for specified target compounds. This “retro-biosynthetic design” approach is aided by advancements in the development of new tools under the umbrella of synthetic biology that facilitate the re-engineering of biological systems. As new pathways are designed and constructed, typical challenges such as low product yields and titers can hamper the development of commercially relevant processes. The sheer volume of chemicals that ultimately need to be produced also requires the use of a broader range of feedstocks than those traditionally employed in bioprocesses. In this talk, Professor Prather will review her group’s sustained efforts to both produce novel compounds through biological synthesis and develop strategies to address the inherent limitations.
Locked Interactive transcript